
Xetonyx CR 25 by Kivonyx Healthcare contains Paroxetine, a selective serotonin reuptake inhibitor (SSRI) that raises serotonin levels in the brain to improve mood. The controlled-release tablet frees the medicine slowly through the day, which keeps levels steady and can reduce stomach upset. Doctors prescribe it for major depression, panic disorder, obsessive compulsive disorder, social anxiety and PTSD. Swallow the tablet whole without crushing or chewing. Improvement usually appears after a few weeks, and the medicine should never be stopped suddenly. Use only as directed by your physician. Pharma franchise partners can contact Digify Pharma for supply.
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Kivonyx Healthcare Pvt. Ltd. is a leading pharmaceutical company in Ahmedabad, with a primary focus on providing high-quality healthcare products to its clients and customers that cater to a diverse range of health disorders. We are deeply committed to offering innovative healthcare solutions that improve patients’ health and enhance their quality of life. In everything we do or engage with, the foundation remains the same; i.e. an unwavering dedication to quality and innovation.
All our products are manufactured in WHO GMP-certified facilities. With the backing of a strong network, our product range reaches the entire nation with a well-structured distribution channel. Thus, we are highly reliable as a brand when it comes to taking care of the ever-evolving needs of the healthcare community. We offer a wide range of pharmaceutical products for improving patient care, ranging from antibiotics and antifungal treatments to advanced vitamin supplements.
We believe in continuous improvement through research and development, enabling us to stay at the forefront of medical advancements. By combining state-of-the-art technology with a patient-centric approach, we ensure that our solutions not only meet but exceed the expectations of the healthcare sector.